Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 SAD of Debio 1450 in Healthy Volunteers
NCT02162199Phase 1Completed
- Sponsor
- Debiopharm
- Start
- Jun 2014
- Primary completion
- Oct 2014
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in staphylococcal infection comparing Debio 1450 with Placebo (2 arms). Primary endpoints: Number of participants with at least one treatment emergent adverse event, Maximum observed plasma concentration and 1 more. Started Jun 2014; status: completed.
02
Drugs
afabicin
03
Conditions
staphylococcal infection
Beyond the preview
Go deeper on NCT02162199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02162199.